Star Equity Holdings, Inc. (NASDAQ: STRR)

Sector: Healthcare Industry: Diagnostics & Research CIK: 0001210708
P/B 0.49
P/E -6.83
P/S 0.22
Market Cap 33.21 Mn
ROIC (Qtr) -6.54
Div Yield % 0.00
Rev 1y % (Qtr) 30.14
Total Debt (Qtr) 22.99 Mn
Debt/Equity (Qtr) 0.34

About

Hudson Global, Inc., represented by the ticker symbol HSON, is a prominent player in the total talent solutions industry, operating under the Hudson RPO brand. The company specializes in delivering customized recruitment outsourcing and comprehensive talent solutions to organizations across the globe. Hudson Global's approach is centered on developing tailored talent solutions that cater to its clients' strategic growth objectives. The company's core business activities encompass a global presence, with direct operations in fourteen countries....

Read more

Stock Price Chart

Analysis

Pros

  • Healthy cash reserves of 16.58M provide 2.37x coverage of short-term debt 7M, demonstrating strong liquidity position and minimal refinancing risk.
  • Operating cash flow of (1.38M) provides exceptional 10.23x coverage of interest expenses (135000), showing strong debt service capability.
  • Strong tangible asset base of 109.30M provides 4.75x coverage of total debt 22.99M, indicating robust asset backing and low credit risk.
  • Tangible assets of 109.30M provide exceptional 31.91x coverage of deferred revenue 3.42M, showing strong service capability backing.
  • Free cash flow of (1.89M) provides exceptional 14.01x coverage of interest expense (135000), showing strong debt service ability.

Cons

  • Operating cash flow of (1.38M) barely covers its investment activities of 6.16M, with a coverage ratio of -0.22, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Operating cash flow of (1.38M) provides insufficient coverage of deferred revenue obligations of 3.42M, which is -0.40x, raising concerns about future service delivery capabilities.
  • The company's operating cash flow of (1.38M) shows concerning coverage of stock compensation expenses of 1.23M, with a -1.12 ratio indicating potential earnings quality issues.
  • High receivables of 36.24M relative to inventory of 7.75M (4.68 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Free cash flow of (1.89M) provides weak coverage of capital expenditures of 511000, with a -3.70 ratio suggesting additional external financing needs for growth initiatives.

Peer Comparison

Companies in the Diagnostics & Research
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TMO Thermo Fisher Scientific Inc. 216.83 Bn 33.00 4.96 35.68 Bn
2 DHR Danaher Corp /De/ 162.47 Bn 46.38 6.69 16.86 Bn
3 IDXX Idexx Laboratories Inc /De 56.88 Bn 55.36 13.65 1.09 Bn
4 A Agilent Technologies, Inc. 39.82 Bn 32.64 5.87 3.41 Bn
5 IQV Iqvia Holdings Inc. 38.85 Bn 30.28 2.44 15.19 Bn
6 NTRA Natera, Inc. 31.32 Bn -101.29 14.80 0.18 Bn
7 MTD Mettler Toledo International Inc/ 28.99 Bn 34.68 7.35 2.21 Bn
8 WAT Waters Corp /De/ 22.92 Bn 35.32 7.38 1.49 Bn

Industry Comparisons

Current Valuation

Metric Value Industry Percentile
EV to Assets 0.14 2.69
EV to Cash from Ops. -12.20 18.14
EV to Debt 0.73 52.51
EV to EBIT -4.86 19.22
EV to EBITDA -7.69 4.35
EV to Free Cash Flow [EV/FCF] -8.90 2.84
EV to Market Cap 0.51 1.52
EV to Revenue 0.11 4.79
Price to Book Value [P/B] 0.49 1.34
Price to Earnings [P/E] -6.83 22.02

Dividend Metrics

Metric Value Industry Percentile
Dividend Coverage Ratio -72.54 -1.96
Dividend Payout Ratio % 0.00 2.83
Dividend per Basic Share 0.00 0.19
FCF Dividend Payout Ratio % 0.00 1.92
Interest Coverage 25.67 -126.58

Growth Metrics

Metric Value Industry Percentile
Capex Growth (1y) % -796.49 -31.50
Cash and Equivalents Growth (1y) % 1.75 21.37
Dividend Growth (1y) % 0.00 0.24
EBIAT Growth (1y) % -37.64 -55.24
EBITDA Growth (1y) % 37.72 -447.96
EBIT Growth (1y) % 12.37 -40.50
EBT Growth (1y) % 11.60 -70.94
EPS Growth (1y) % -36.84 -70.02
FCF Growth (1y) % -23.82 56.33
Gross Profit Growth (1y) % 6.03 185.11

Liquidity Ratios

Metric Value Industry Percentile
Asset Utilization Ratio 1.27 0.56
Cash Payout Ratio 0.00 0.01
Cash Ratio 0.51 1.21
Current Ratio 2.07 2.64
Debt to Equity Ratio 0.34 -0.80
Interest Cover Ratio 25.67 -126.58
Times Interest Earned 25.67 -126.58

Profitability

Metric Value Industry Percentile
EBITDA Margin % -1.30 -129.91
EBIT Margin % -2.33 -156.71
EBT Margin % -2.24 -162.23
Gross Margin % 49.20 47.70
Net Profit Margin % -3.30 -189.30